LysoPC(14:0/0:0)-d7
Based on 1 Customer Validation
LysoPC(14:0/0:0)-d7 (14:0 Lyso PC-d7) is deuterium labeled LysoPC(14:0/0:0). LysoPC(14:0/0:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. LysoPC(14:0/0:0) has potent antispasmodic effect.
For research use only. We do not sell to patients.
- Purity: 95.4%
- Formula: C22H39D7NO7P
- Molecular Weight:474.62
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
All Endogenous Metabolite Isoforms
More
Biological Activity
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
Unlabeled Cas 20559-16-4
-
Appearance Solid
-
Molecular Weight 474.62
-
Formula C22H39D7NO7P
-
Color White to off-white
-
SMILES
O[C@H](COC(CCCCCCCCCCC([2H])(C([2H])(C([2H])([2H])[2H])[2H])[2H])=O)COP(OCC[N+](C)(C)C)([O-])=O
-
Synonyms
14:0 Lyso PC-d7; 1-myristoyl-sn-glycero-3-phosphatidylcholine-d7
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Purity & Documentation
-
Data Sheet (263 KB)
-
SDS (558 KB)
- English - EN (558 KB)
- Français - FR (558 KB)
- Deutsch - DE (558 KB)
- Norwegian - NO (558 KB)
- Español - ES (558 KB)
- Swedish - SV (558 KB)
- Italian - IT (558 KB)
- Korean - KR (558 KB)
- Portuguese - PT (558 KB)
-
Handling Instructions (2659 KB)
References
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]
[2]. Tsukatani H, et al.Comparison of antispasmodic effect of synthetic lysolecithins with various fatty acid moieties on guinea pig ileum.J Pharmacobiodyn. 1984 Jun;7(6):400-6. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)